CBIO insider trading
Crescent Biopharma, Inc.
In the past 36 days, 7 insiders sold $286K.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Joshua T Brumm Chief Executive Officer |
$160K 9,447 sh @ $16.91 |
−3.4% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Jonathan McNeill President and COO |
$77K 4,570 sh @ $16.90 |
−3.3% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Jan Pinkas Chief Scientific Officer |
$12K 658 sh @ $17.90 |
−3.0% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Ellie Eunkyung Im Chief Medical Officer |
$11K 623 sh @ $17.90 |
−2.8% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Barbara Harlin Bispham See Remarks |
$11K 620 sh @ $17.90 |
−3.2% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Richard William Scalzo Chief Financial Officer |
$10K 568 sh @ $17.90 |
−2.8% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Ryan Lynch See Remarks |
$4K 240 sh @ $17.90 |
−1.7% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |